APstem Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3M

  • Investors
  • 5

APstem Therapeutics General Information

Description

Developer of a novel stem cell therapy designed to eradicate difficult-to-heal diseases and overcome the challenges of aging. The company's therapy uses a novel stem cell technology that targets remedies for injuries and degenerative diseases, including diabetic ulcers, diabetes, neural damage, liver diseases, and aging-associated diseases, enabling patients to get therapies that can expand rapidly and differentiate into cell lineages originating from germ layers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 48371 Fremont Boulevard
  • Suite 103
  • Fremont, CA 94538
  • United States
+1 (510)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 48371 Fremont Boulevard
  • Suite 103
  • Fremont, CA 94538
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

APstem Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 07-Sep-2023 $3M Completed Pre-Clinical Trials
4. Seed Round 01-Sep-2020 Completed Pre-Clinical Trials
3. Seed Round 01-May-2019 Completed Pre-Clinical Trials
2. Seed Round 17-Jan-2018 $1M $1M Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2017 Completed Stealth
To view APstem Therapeutics’s complete valuation and funding history, request access »

APstem Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed 1,297,000 $0.000010 $0.79 $0.79 1x $0.79 11.55%
To view APstem Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

APstem Therapeutics Patents

APstem Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4788793-A1 Generation of stem cells with high plasticity Pending 06-Oct-2023
WO-2025076394-A1 Generation of stem cells with high plasticity Inactive 06-Oct-2023
AU-2019345279-A1 Human pluripotent adult stem cells Active 21-Sep-2018
AU-2019345279-B2 Human pluripotent adult stem cells Active 21-Sep-2018
AU-2023200406-A1 Human pluripotent adult stem cells Inactive 21-Sep-2018 C12N5/0607
To view APstem Therapeutics’s complete patent history, request access »

APstem Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

APstem Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beyond Ventures Venture Capital Minority
Oriza Ventures Venture Capital Minority
InnoSpring Venture Capital Minority
MFund Venture Capital Minority
StartX (US) Accelerator/Incubator Minority
To view APstem Therapeutics’s complete investors history, request access »

APstem Therapeutics FAQs

  • When was APstem Therapeutics founded?

    APstem Therapeutics was founded in 2017.

  • Where is APstem Therapeutics headquartered?

    APstem Therapeutics is headquartered in Fremont, CA.

  • What is the size of APstem Therapeutics?

    APstem Therapeutics has 5 total employees.

  • What industry is APstem Therapeutics in?

    APstem Therapeutics’s primary industry is Drug Discovery.

  • Is APstem Therapeutics a private or public company?

    APstem Therapeutics is a Private company.

  • What is APstem Therapeutics’s current revenue?

    The current revenue for APstem Therapeutics is .

  • How much funding has APstem Therapeutics raised over time?

    APstem Therapeutics has raised $7.3M.

  • Who are APstem Therapeutics’s investors?

    Beyond Ventures, Oriza Ventures, InnoSpring, MFund, and StartX (US) have invested in APstem Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process